Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Patrick Kelly currently holds 114,507 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Patrick Kelly has been a net seller of DCPH stock. They have purchased $8.3K and sold $6.5M worth of shares.
Thomas Patrick Kelly's most recent insider trade was on Jun 11, 2024, when they sold 82,265 shares at $0.00 per share.
Thomas Patrick Kelly serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 79 insider transactions totaling $6.5M over their tenure at the company.
Thomas Patrick Kelly holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Thomas Patrick Kelly has shown a selling trading pattern, with $8.3K in total purchases and $6.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Patrick Kelly was on May 11, 2020, when they sold $517.5K worth of DCPH shares. This transaction involved 9,395 shares at $55.08 per share.
Thomas Patrick Kelly currently owns 114,507 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Patrick Kelly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Patrick Kelly has 79 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Thomas Patrick Kelly and 40,000+ other insiders.